NVAX logo

Novavax, Inc. (NVAX) Cash and Cash Equivalents

Annual Cash & Cash Equivalents:

$933.74M+$354.81M(+61.29%)
December 31, 2024

Summary

  • As of today, NVAX annual cash & cash equivalents is $933.74 million, with the most recent change of +$354.81 million (+61.29%) on December 31, 2024.
  • During the last 3 years, NVAX annual cash & cash equivalents has fallen by -$592.86 million (-38.84%).
  • NVAX annual cash & cash equivalents is now -38.84% below its all-time high of $1.53 billion, reached on December 31, 2021.

Performance

NVAX Cash and Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVAXbalance sheet metrics

Quarterly Cash & Cash Equivalents:

$773.71M+$150.66M(+24.18%)
September 30, 2025

Summary

  • As of today, NVAX quarterly cash & cash equivalents is $773.71 million, with the most recent change of +$150.66 million (+24.18%) on September 30, 2025.
  • Over the past year, NVAX quarterly cash & cash equivalents has dropped by -$146.37 million (-15.91%).
  • NVAX quarterly cash & cash equivalents is now -63.53% below its all-time high of $2.12 billion, reached on June 30, 2021.

Performance

NVAX Quarterly Cash & Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVAXbalance sheet metrics

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

NVAX Cash and Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+61.3%-15.9%
3Y3 Years-38.8%-40.1%
5Y5 Years+1041.9%+35.5%

NVAX Cash and Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-38.8%+61.3%-42.6%+57.6%
5Y5-Year-38.8%+1041.9%-63.5%+57.6%
All-TimeAll-Time-38.8%>+9999.0%-63.5%>+9999.0%

NVAX Cash and Cash Equivalents History

DateAnnualQuarterly
Sep 2025
-
$773.71M(+24.2%)
Jun 2025
-
$623.05M(-16.0%)
Mar 2025
-
$742.16M(-20.5%)
Dec 2024
$933.74M(+61.3%)
$933.74M(+1.5%)
Sep 2024
-
$920.08M(-13.2%)
Jun 2024
-
$1.06B(+115.9%)
Mar 2024
-
$491.04M(-15.2%)
Dec 2023
$578.93M(-57.0%)
$578.93M(-12.5%)
Sep 2023
-
$661.50M(+28.1%)
Jun 2023
-
$516.27M(-18.7%)
Mar 2023
-
$635.28M(-52.8%)
Dec 2022
$1.35B(-11.8%)
$1.35B(+4.3%)
Sep 2022
-
$1.29B(-6.8%)
Jun 2022
-
$1.39B(-12.4%)
Mar 2022
-
$1.58B(+3.7%)
Dec 2021
$1.53B(+89.7%)
$1.53B(-21.5%)
Sep 2021
-
$1.95B(-8.3%)
Jun 2021
-
$2.12B(+4.5%)
Mar 2021
-
$2.03B(+152.2%)
Dec 2020
$804.93M(+884.4%)
$804.93M(+40.9%)
Sep 2020
-
$571.18M(-6.2%)
Jun 2020
-
$609.07M(+149.4%)
Mar 2020
-
$244.25M(+198.7%)
Dec 2019
$81.77M(-20.6%)
$81.77M(+8.3%)
Sep 2019
-
$75.52M(-2.0%)
Jun 2019
-
$77.03M(-27.9%)
Mar 2019
-
$106.82M(+3.7%)
Dec 2018
$102.98M(-44.5%)
$102.98M(-28.8%)
Sep 2018
-
$144.69M(-18.4%)
Jun 2018
-
$177.24M(+8.5%)
Mar 2018
-
$163.31M(-12.0%)
Dec 2017
$185.54M(-30.2%)
$185.54M(-9.5%)
Sep 2017
-
$204.99M(-5.8%)
Jun 2017
-
$217.50M(-8.8%)
Mar 2017
-
$238.50M(-10.3%)
Dec 2016
$265.79M(+0.1%)
$265.79M(-19.9%)
Sep 2016
-
$331.80M(-17.0%)
Jun 2016
-
$399.67M(-13.8%)
Mar 2016
-
$463.49M(+74.5%)
Dec 2015
$265.62M(+57.8%)
$265.62M(-8.5%)
Sep 2015
-
$290.19M(-7.9%)
Jun 2015
-
$314.94M(-3.9%)
Mar 2015
-
$327.74M(+94.7%)
Dec 2014
$168.35M(+25.2%)
$168.35M(-5.5%)
Sep 2014
-
$178.09M(+16.7%)
Jun 2014
-
$152.66M(+34.9%)
Mar 2014
-
$113.16M(-15.9%)
Dec 2013
$134.49M(+198.2%)
$134.49M(-8.2%)
Sep 2013
-
$146.53M(+260.9%)
Jun 2013
-
$40.60M(-8.8%)
Mar 2013
-
$44.50M(-1.3%)
Dec 2012
$45.10M
$45.10M(+54.2%)
Sep 2012
-
$29.25M(+10.2%)
Jun 2012
-
$26.54M(+28.1%)
Mar 2012
-
$20.72M(+5.7%)
Sep 2011
-
$19.60M(-12.2%)
Jun 2011
-
$22.32M(-6.7%)
Mar 2011
-
$23.92M(-35.1%)
DateAnnualQuarterly
Sep 2010
-
$36.86M(+37.6%)
Jun 2010
-
$26.79M(-18.6%)
Mar 2010
-
$32.89M(-23.4%)
Dec 2009
$42.95M(+26.7%)
$42.95M(+24.9%)
Sep 2009
-
$34.38M(+10.2%)
Jun 2009
-
$31.19M(+21.9%)
Mar 2009
-
$25.59M(-24.5%)
Dec 2008
$33.90M(-27.1%)
$33.90M(-25.1%)
Sep 2008
-
$45.24M(+26.1%)
Jun 2008
-
$35.88M(-12.2%)
Mar 2008
-
$40.89M(-12.0%)
Dec 2007
$46.49M(-36.8%)
$46.49M(-11.0%)
Sep 2007
-
$52.26M(-14.6%)
Jun 2007
-
$61.22M(-9.5%)
Mar 2007
-
$67.63M(-8.1%)
Dec 2006
$73.59M(+130.8%)
$73.59M(+245.6%)
Sep 2006
-
$21.29M(-72.9%)
Jun 2006
-
$78.60M(-6.4%)
Mar 2006
-
$83.94M(+163.2%)
Dec 2005
$31.89M(+78.4%)
$31.89M(+359.3%)
Sep 2005
-
$6.94M(+56.3%)
Jun 2005
-
$4.44M(-51.7%)
Mar 2005
-
$9.20M(-48.5%)
Dec 2004
$17.88M(-35.3%)
$17.88M(-35.0%)
Sep 2004
-
$27.50M(+76.0%)
Jun 2004
-
$15.62M(-28.6%)
Mar 2004
-
$21.89M(-20.8%)
Dec 2003
$27.63M(+819.6%)
$27.63M(+357.1%)
Sep 2003
-
$6.04M(-37.2%)
Jun 2003
-
$9.63M(-32.8%)
Mar 2003
-
$14.32M(+376.5%)
Dec 2002
$3.00M(-85.0%)
$3.00M(-60.6%)
Sep 2002
-
$7.63M(-52.1%)
Jun 2002
-
$15.93M(+46.3%)
Mar 2002
-
$10.88M(-45.7%)
Dec 2001
$20.05M(+34.9%)
$20.05M(-14.0%)
Sep 2001
-
$23.30M(+103.7%)
Jun 2001
-
$11.44M(+28.6%)
Mar 2001
-
$8.89M(-40.2%)
Dec 2000
$14.86M(+2023.4%)
$14.86M(+47.8%)
Sep 2000
-
$10.06M(-18.1%)
Jun 2000
-
$12.29M(-16.4%)
Mar 2000
-
$14.69M(+1302.0%)
Dec 1999
$700.00K(-30.0%)
-
Sep 1999
-
$1.05M(-62.2%)
Jun 1999
-
$2.78M(+756.8%)
Mar 1999
-
$324.00K(-95.5%)
Dec 1998
$1.00M(-73.7%)
-
Sep 1998
-
$7.22M(-13.5%)
Jun 1998
-
$8.34M(-9.2%)
Mar 1998
-
$9.19M(+141.8%)
Dec 1997
$3.80M(+52.0%)
$3.80M(-20.8%)
Sep 1997
-
$4.80M(-17.2%)
Jun 1997
-
$5.80M(-14.7%)
Mar 1997
-
$6.80M(+172.0%)
Dec 1996
$2.50M
$2.50M(+19.0%)
Sep 1996
-
$2.10M(-30.0%)
Jun 1996
-
$3.00M(-23.1%)
Mar 1996
-
$3.90M

FAQ

  • What is Novavax, Inc. annual cash & cash equivalents?
  • What is the all-time high annual cash & cash equivalents for Novavax, Inc.?
  • What is Novavax, Inc. annual cash & cash equivalents year-on-year change?
  • What is Novavax, Inc. quarterly cash & cash equivalents?
  • What is the all-time high quarterly cash & cash equivalents for Novavax, Inc.?
  • What is Novavax, Inc. quarterly cash & cash equivalents year-on-year change?

What is Novavax, Inc. annual cash & cash equivalents?

The current annual cash & cash equivalents of NVAX is $933.74M

What is the all-time high annual cash & cash equivalents for Novavax, Inc.?

Novavax, Inc. all-time high annual cash & cash equivalents is $1.53B

What is Novavax, Inc. annual cash & cash equivalents year-on-year change?

Over the past year, NVAX annual cash & cash equivalents has changed by +$354.81M (+61.29%)

What is Novavax, Inc. quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of NVAX is $773.71M

What is the all-time high quarterly cash & cash equivalents for Novavax, Inc.?

Novavax, Inc. all-time high quarterly cash & cash equivalents is $2.12B

What is Novavax, Inc. quarterly cash & cash equivalents year-on-year change?

Over the past year, NVAX quarterly cash & cash equivalents has changed by -$146.37M (-15.91%)
On this page